Towards a functional neuroanatomy of conscious perception and its modulation by volition: implications of human auditory neuroimaging studies.
Conscious sensory perception and its modulation by volition are integral to human mental life. Functional neuroimaging techniques provide a direct means of identifying and characterizing in vivo the systems-level patterns of brain activity associated with such mental functions. In a series of positron emission tomography activation experiments, we and our colleagues have examined a range of normal and abnormal auditory states that, when contrasted, provide dissociations relevant to the question of the neural substrates of sensory awareness. These dissociations include sensory awareness in the presence and absence of external sensory stimuli, the transition from sensory unawareness to awareness (or vice versa) in the presence of sensory stimuli, and sensory awareness with and without volition. The auditory states studied include hallucinations, mental imagery, cortical deafness modulated by attention, and hearing modulated by sedation. The results of these studies highlight the distributed nature of the functional neuroanatomy that is sufficient, if not necessary, for sensory awareness. The probable roles of unimodal association (as compared with primary) cortices, heteromodal cortices, limbic/paralimbic regions and subcortical structures (such as the thalamus) are discussed. In addition, interactions between pre- and post-rolandic regions are examined in the context of top-down, volitional modulation of sensory awareness.
Silbersweig
D A
DA
Functional Neuroimaging Laboratory, New York Hospital, Cornell Medical Center, NY 10021, USA.
Stern
E
E
D001307:Auditory Perception / Q000187:drug effects / Q000502:physiology*; D001921:Brain / Q000033:anatomy & histology / Q000000981:diagnostic imaging / Q000502:physiology*; D003243:Consciousness / Q000502:physiology*; D003638:Deafness / Q000000981:diagnostic imaging / Q000503:physiopathology; D018757:GABA Modulators / Q000494:pharmacology; D006212:Hallucinations / Q000000981:diagnostic imaging / Q000503:physiopathology; D006801:Humans; D008874:Midazolam / Q000494:pharmacology; D012559:Schizophrenia / Q000000981:diagnostic imaging / Q000503:physiopathology; D014055:Tomography, Emission-Computed; D014836:Volition / Q000502:physiology*
D018757:GABA Modulators; D008874:Midazolam